trading-news is updating strong results from biopharma long term stocks list, we signal in red recent strong perfomer stock and new position takes: ANPI RECEIVE FDA CLEARENCE FOR PRODUCT CTIC SIGNS OF RECOVERY FROM 2,2 SELL OFF: TICKER BUY AREA QUOTE NOW POSITION DRIVER SVNT (NASDAQ) 7,10 6,8 SHORT TERM KRYSTEXXA NPSP (NASDAQ) 3,1 USD 3,8 LONG TERM STRONG CONSENSUS SCLN (NASDAQ) 2,25 USD 2,2 LONG TERM ZADAXIN SALES MAPP (NASDAQ) 8 USD(posts from 5/26) PROFIT TAKED(+45%) LEVADEX VNDA (NASDAQ) 8 USD (see old post 5/8) PROFIT TAKED(+80%) FANAT CLDA (NASDAQ) 15,7 USD 12,2 LONG TERM VILAZODONE CTIC (NASDAQ) 2,10 USD 1,7 LONG TERM PIXANTRONE/OPAXIO RESULTS ANPI (NASDAQ) 2 USD 2,4 LONG TERM OPTIOM® FDA CLEARENCE MEDX (NASDAQ) 7,5 USD 7,2 LONG TERM RECENT PRODUCTS RESULTS MNTA (NASDAQ) 8,9 USD 9,4 LONG TERM STRONG CONSENSUS ACAD (NASDAQ) 2,6 USD(see old post 5/6) 2,4 LONG TERM BIOVAIL PACT ACOR (NASDAQ) 24 USD (see old post 5/6) 26,1 LONG TERM FAMPRIDINE-SR BDSI (NASDAQ) PROFIT TAKED 6,3 (+18%) ONSOLIS DNDN (NASDAQ) 22 USD (see old post 4/27) 25,1 LONG TERM PROVENGE SPPI (NASDAQ) 4 USD (see ols post 5/12) 5,2 LONG TERM ZEVALIN/FUSILEV
Fonte:
biopharma long term stock list update
Articoli correlati:
Nessun commento per ora.
Segui il feed dei commenti a questo post
Scrivi un commento






Nessun Commento